SERPINB2 and hepatocellular carcinoma: Using immunohistochemistry, Zhou et al. [38] revealed that the proportion of SERPINB2-positive cells in HCC tissues was significantly lower than that in non-cancerous tissues (26.9% vs. 71.8%, respectively).